ACC Optima mucolytic

ACC Optima is a well-known mucolytic medication used to treat respiratory conditions involving thick mucus. The brand is deeply rooted in European pharmaceutical history, specifically originating from the scientific developments within the German pharmaceutical industry. It is primarily used to facilitate the coughing up of phlegm in patients with bronchitis or other respiratory infections.

Currently, the brand is owned by Sandoz, which was a long-time division of the Swiss multinational Novartis. In a significant corporate shift in late 2023, Sandoz was spun off into an independent, publicly traded company specializing in generic pharmaceuticals and biosimilars. While production often occurs at major European manufacturing sites in Germany and Slovenia, the brand's strategic and corporate headquarters remain in Switzerland.

In the Polish market, where this specific packaging is found, the product is distributed and managed by Sandoz Polska Sp. z o.o., ensuring compliance with local medical regulations and supply chain requirements.